TriApex at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

TriApex takes part in 4 sessions at ACT 2026 in San Antonio. Its program centres on nonclinical safety for new drug types, from a tiered evaluation framework for antibody-drug conjugates to complement activation risk from chemically modified antisense oligonucleotides. It also covers gene therapy injected into the inner ear and the toxicity of lipid-delivered siRNA drugs in monkeys.

OrganizationACT 2026 Attendance
TriApex
Nanjing, China
◆Platinum Supporter
Contract research organizations (CROs)Platinum Supporter
Chinese nonclinical and clinical CRO with NMPA GLP certification, presenting work on ADCs, oligonucleotides, siRNA and gene therapy.
Talk
Mon Nov 16
7:00am–7:55am
Poster
Mon Nov 16
5:00pm–6:30pm
A Tiered Strategy for Evaluating In Vivo Complement Activation Risk of Chemically-Modified ASOs in Nonclinical Studies (P505)
Nelson Exhibit Ballroom · Poster P505
Immunotoxicology · Biologics and new modalities
Poster
Mon Nov 16
5:00pm–6:30pm
Biodistribution and Neurotoxicity Assessment of rAAV1 Gene Therapy after Round Window Membrane Injection (P120)
Nelson Exhibit Ballroom · Poster P120
Biologics and new modalities · Neurotoxicology
Poster
Mon Nov 16
5:00pm–6:30pm
Toxicokinetic Characteristics and Toxicity Findings of Lipid-Delivered Small Interfering RNA Drugs in Cynomolgus Studies (P139)
Nelson Exhibit Ballroom · Poster P139
Biologics and new modalities · Bioanalysis and biomarkers

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from TriApex

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction